AI in Biotech: Solving R&D Complexity, Data Silos, and Time-to-Market Pressures for Life Sciences Innovators

Despite decades of advancements in medical science, there are still many major health issues facing humanity. Diseases like Alzheimer’s, diabetes, and cancer are still unpredictable and challenging to treat. These disorders affect millions of individuals globally, frequently with few treatment options and unsatisfactory results. Despite some success, traditional medicine frequently fails to adequately address the complexities of these conditions. For example, there are currently no viable treatments for Alzheimer’s disease, which affect millions of people worldwide, to stop or reverse its course. AI in biotech is where it comes into play at this point.